Aspirin use and risk of colorectal cancer according to BRAF mutation status

R Nishihara, P Lochhead, A Kuchiba, S Jung… - Jama, 2013 - jamanetwork.com
Importance Aspirin use reduces the risk of colorectal carcinoma. Experimental evidence
implicates a role of RAF kinases in up-regulation of prostaglandin-endoperoxide synthase 2 …
被引用次数：255 相关文章
[HTML] nih.gov

[HTML][HTML] Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status

R Nishihara, P Lochhead, A Kuchiba… - JAMA: the journal of …, 2013 - ncbi.nlm.nih.gov
Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status.

R Nishihara, P Lochhead, A Kuchiba… - JAMA: Journal of …, 2013 - search.ebscohost.com
Importance Aspirin use reduces the risk of colorectal carcinoma. Experimental evidence
implicates a role of RAF kinases in up-regulation of prostaglandin-endoperoxide synthase 2 …

Aspirin use and risk of colorectal cancer according to BRAF mutation status.

R Nishihara, P Lochhead, A Kuchiba, SY Jung… - 2013 - cabidigitallibrary.org
Importance: Aspirin use reduces the risk of colorectal carcinoma. Experimental evidence
implicates a role of RAF kinases in up-regulation of prostaglandin-endoperoxide synthase 2 …

Aspirin use and risk of colorectal cancer according to BRAF mutation status

R Nishihara, P Lochhead, A Kuchiba, S Jung… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Importance Aspirin use reduces the risk of colorectal carcinoma. Experimental evidence
implicates a role of RAF kinases in up-regulation of prostaglandin-endoperoxide synthase 2 …

[引用][C] Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status

R NISHIHARA, P LOCHHEAD… - JAMA, the journal of …, 2013 - pascal-francis.inist.fr
Author NISHIHARA, Reiko 1 4; LOCHHEAD, Paul 1 7; SPIEGELMAN, Donna 2 5 6;
EUNYOUNG CHO 2; GIOVANNUCCI, Edward 2 4 5; FUCHS, Charles S 1 2; CHAN, Andrew …

Aspirin use and risk of colorectal cancer according to BRAF mutation status

R Nishihara, P Lochhead, A Kuchiba, S Jung… - JAMA: Journal of the …, 2013 - hero.epa.gov
IMPORTANCE: Aspirin use reduces the risk of colorectal carcinoma. Experimental evidence
implicates a role of RAF kinases in up-regulation of prostaglandin-endoperoxide synthase 2 …

Aspirin use and risk of colorectal cancer according to BRAF mutation status

R Nishihara, P Lochhead, A Kuchiba… - JAMA-Journal of the …, 2013 - pure.ewha.ac.kr
Importance: Aspirin use reduces the risk of colorectal carcinoma. Experimental evidence
implicates a role of RAF kinases in up-regulation of prostaglandin-endoperoxide synthase 2 …
[PDF] researchgate.net

[PDF][PDF] Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status

R Nishihara, P Lochhead, A Kuchiba, S Jung… - JAMA, 2013 - researchgate.net
Objective To examine whether the association of aspirin intake with colorectal cancer risk
differs according to status of tumor BRAF oncogene mutation. Design and Setting We …

Aspirin use and risk of colorectal cancer according to BRAF mutation status

R Nishihara, P Lochhead, A Kuchiba, S Jung… - JAMA, 2013 - abdn.elsevierpure.com
Importance Aspirin use reduces the risk of colorectal carcinoma. Experimental evidence
implicates a role of RAF kinases in up-regulation of prostaglandin-endoperoxide synthase 2 …